Daewoong Pet Launches Low-Dose UDCA Tablet... "Reduced Compounding Burden"
"Expanding Product Supply Through Veterinary Clinics"
On June 8, Daewoong Pet announced the launch of 'UDCA Tablet 50mg,' a new low-dose lineup of ursodeoxycholic acid (UDCA) formulations for animals.
UDCA Tablet 50mg is the first product in Korea to be approved as a 50mg UDCA tablet for veterinary use. It was developed to improve dosing convenience and enable weight-based prescriptions for small dogs and cats. Previously, animals with lower body weights were often prescribed split or crushed high-dose tablets. However, UDCA Tablet 50mg reduces the burden of such compounding and expands the options for tablet-based prescriptions.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A representative from Daewoong Pet stated, "Interest in managing bile acid metabolism in companion animals is growing. We will strengthen product supply and information sharing through veterinary clinics to provide a more convenient and stable UDCA administration environment for pets."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.